Yes, and with almost half of the patients in the aGVHD trial not having biomarkers to compare, the potential for bias in the results becomes even more significant.
Yes, and with almost half of the patients in the aGVHD trial not...
-
- There are more pages in this discussion • 319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.000(0.00%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | $1.00 | $1.097M | 1.088M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 27017 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 38506 | 21 |
View Market Depth
| Last trade - 12.58pm 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |